Team
VRG Therapeutics among the top 30 startups to participate in the Labena Ventures Accelerator Program!

We are thrilled to share that VRG Therapeutics has been selected among the top 30 startups to participate in the Labena Ventures Accelerator Program!

Márton Megyeri Ph.D., our VP of Scientific Operations will be attending the program's bootcamp this week and is looking forward to connect with other innovative startups from the region. Exciting times ahead!

https://www.linkedin.com/feed/update/urn:li:activity:7205186746337103872/

Introduction
Link icon purple
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
June 11, 2024
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
June 11, 2024
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
Introduction
Link icon purple
Latest
News
The latest industry news, interviews, technologies, and resources.
View All News
CREATe-1
May 24, 2024
By VRG Therapeutics
Publication - Chemogenetic Inhibition of the Lateral Hypothalamus Effectively Reduces Food Intake in Rats in a Translational Proof-of-Concept Study
White arrow icon up and right direction redirecting to Partner with US page
Conference
May 22, 2024
By VRG Therapeutics
BIO 2024 San Diego
White arrow icon up and right direction redirecting to Partner with US page
Latest
News
The latest industry news, interviews, technologies, and resources.
CREATe-1
May 24, 2024
By VRG Therapeutics
Publication - Chemogenetic Inhibition of the Lateral Hypothalamus Effectively Reduces Food Intake in Rats in a Translational Proof-of-Concept Study
White arrow icon up and right direction redirecting to Partner with US page
Conference
May 22, 2024
By VRG Therapeutics
BIO 2024 San Diego
White arrow icon up and right direction redirecting to Partner with US page
View All News
Learn More
Million ways to improve life
Learn More
Million ways to improve life